In Brief: FDA's Ron Johnson
This article was originally published in The Gray Sheet
FDA's Ron Johnson: Director of FDA's Pacific Region office joins Quintiles/BRI consulting firm, leaving FDA after 29 years with the agency. Johnson will work at the firm's San Francisco office as executive director for West Coast operations, quality systems. Johnson, whose recent projects have included work on an FDA third-party inspection proposal, became director of FDA's Pacific Region in 1994 after a three-year stint as director of the Office of Compliance in the agency's Center for Devices and Radiological Health ("The Gray Sheet" March 21, 1994, I&W-1). The Pacific Region director slot is being filled on a rotating weekly basis by FDA district officials...
You may also be interested in...
The addition of the question “Was this device serviced by a third party servicer?” to adverse event reports filed through the US FDA’s electronic Medical Device Reporting system could prove helpful for the agency and device makers, experts tell Medtech Insight. Industry has long complained about poor work performed by servicers – and loudly groused that they’re not regulated.
Attorneys tell Medtech Insight a recent proposal to review regulations every 10 years could lift some burdens from the medical device industry, but warned that the full effects may not be seen for some time.
A nasal spray formulated using compounds already approved by regulatory bodies in Europe and the US can “prevent and slow” transmission of COVID-19, according to UK researchers who are now seeking a partner to commercialize the product.